Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study*
暂无分享,去创建一个
F. Cavalli | H. van de Velde | Jie Jin | G. Verhoef | T. Robak | Jun Zhu | Hui-Qiang Huang | N. Siritanaratkul | O. Samoilova | J. Mayer | X. Hong | J. Pereira | Ting Liu | H. Pylypenko | R. Okamoto | E. Osmanov | L. Pei | B. Rooney | Huiqiang Huang | H. V. D. van de Velde